Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease

MLA

Heap, Graham A., et al. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-Induced Nephrotoxicity in Inflammatory Bowel Disease. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1233895135&authtype=sso&custid=ns315887.

APA

Heap, G. A., Halfvarson, J., & Ahmad, T. (2016). Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Chicago

Heap, Graham A., Jonas Halfvarson, and Tariq Ahmad. 2016. “Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-Induced Nephrotoxicity in Inflammatory Bowel Disease.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1233895135&authtype=sso&custid=ns315887.